Skip to main content
Erschienen in: Surgical Endoscopy 3/2017

21.07.2016 | New Technology

Superior mesenteric–portal vein resection during laparoscopic pancreatoduodenectomy

verfasst von: Igor E. Khatkov, Roman E. Izrailov, Arthur A. Khisamov, Pavel S. Tyutyunnik, Abraham Fingerhut

Erschienen in: Surgical Endoscopy | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Laparoscopic pancreatoduodenectomy (LPD) with concomitant resection of major portal vessels has recently emerged as feasible and safe, with similar morbidity and mortality as well as oncologic outcome compared with patients undergoing open PD with major vascular resection.

Materials and methods

Of a consecutive series of 133 LPD, eight patients underwent concomitant superior mesenteric vein/portal vein (SMV/PV) resection and reconstruction with the intent of achieving a R0 resection.

Results

Four of these eight patients had tangential resection followed by lateral wall repair with Prolene 4.0. One patient had tangential resection with patch reconstruction. Three patients had circular venous resection: One had end-to-end primary venous reconstruction, and two patients had a prosthetic vascular graft interposition. There was no operative mortality. The SMV/PV was patent in all patients postoperatively on ultrasound Doppler or CT scans. Two patients (who underwent circular venous resection) had postoperative complications. One 77-year-old patient with preexisting cardiovascular disease died of heart failure on postoperative day 2, while another (undergoing prosthetic graft reconstruction) had postoperative bilioenteric anastomotic dehiscence and underwent immediate re-laparoscopy for repair.

Conclusions

In our experience, LPD with concomitant major venous resection is feasible even in cases of longitudinal venous invasion. Further studies are needed to evaluate the role of laparoscopy in borderline pancreatic cancer.
Literatur
1.
Zurück zum Zitat Lopez NE, Prendergast C, Lowy AM (2014) Borderline resectable pancreatic cancer: definitions and management. World J Gastroenterol 20:10740–10751CrossRefPubMedPubMedCentral Lopez NE, Prendergast C, Lowy AM (2014) Borderline resectable pancreatic cancer: definitions and management. World J Gastroenterol 20:10740–10751CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, Madura JA, Wiebke EA, Lillemoe KD (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 10:1338–1345CrossRefPubMed Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, Madura JA, Wiebke EA, Lillemoe KD (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 10:1338–1345CrossRefPubMed
3.
Zurück zum Zitat Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14:1442–1452CrossRefPubMed Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14:1442–1452CrossRefPubMed
4.
Zurück zum Zitat Siriwardana HPP, Siriwardena AK (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93(6):662–673CrossRefPubMed Siriwardana HPP, Siriwardena AK (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93(6):662–673CrossRefPubMed
5.
Zurück zum Zitat Yu XZ, Li J, Fu DL, Di Y, Yang F, Hao SJ, Jin C (2014) Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis. EJSO 40:371–378CrossRefPubMed Yu XZ, Li J, Fu DL, Di Y, Yang F, Hao SJ, Jin C (2014) Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis. EJSO 40:371–378CrossRefPubMed
6.
Zurück zum Zitat Palanivelu C, Rajan PS, Rangarajan M, Vaithiswaran V, Senthilnathan P, Parthasarathi R et al (2009) Evolution in techniques of laparoscopic pancreaticoduodenectomy: a decade long experience from a tertiary center. J Hepatobiliary Pancreat Surg 16:731–740CrossRefPubMed Palanivelu C, Rajan PS, Rangarajan M, Vaithiswaran V, Senthilnathan P, Parthasarathi R et al (2009) Evolution in techniques of laparoscopic pancreaticoduodenectomy: a decade long experience from a tertiary center. J Hepatobiliary Pancreat Surg 16:731–740CrossRefPubMed
7.
Zurück zum Zitat Kendrick ML, Cusati D (2010) Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg 145:19–23CrossRefPubMed Kendrick ML, Cusati D (2010) Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg 145:19–23CrossRefPubMed
8.
Zurück zum Zitat Asbun HJ, Stauffer JA (2012) Laparoscopic vs open pancreaticoduodenectomy: overall outcomes and severity of complications using the accordion SEVERITY grading system. J Am Coll Surg 215:810–819CrossRefPubMed Asbun HJ, Stauffer JA (2012) Laparoscopic vs open pancreaticoduodenectomy: overall outcomes and severity of complications using the accordion SEVERITY grading system. J Am Coll Surg 215:810–819CrossRefPubMed
9.
10.
Zurück zum Zitat Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML (2014) Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg 260(4):633–638CrossRefPubMed Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML (2014) Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg 260(4):633–638CrossRefPubMed
11.
Zurück zum Zitat Croome KP, Farnell MB, Que FG, Reid-Lombardo K, Truty MJ, Nagorney DM, Kendrick ML (2015) Pancreaticoduodenectomy with major vascular resection: a comparison of Laparoscopic versus open approaches. J Gastrointest Surg 19(1):189–194. doi:10.1007/s11605-014-2644-8 Discussion 194 CrossRefPubMed Croome KP, Farnell MB, Que FG, Reid-Lombardo K, Truty MJ, Nagorney DM, Kendrick ML (2015) Pancreaticoduodenectomy with major vascular resection: a comparison of Laparoscopic versus open approaches. J Gastrointest Surg 19(1):189–194. doi:10.​1007/​s11605-014-2644-8 Discussion 194 CrossRefPubMed
12.
Zurück zum Zitat Kendrik ML, Sciabas GM (2011) Major venous resection during total laparoscopic pancreaticoduodenectomy. HPB (Oxf) 13:454–458CrossRef Kendrik ML, Sciabas GM (2011) Major venous resection during total laparoscopic pancreaticoduodenectomy. HPB (Oxf) 13:454–458CrossRef
13.
Zurück zum Zitat Khatkov IE, Izrailov RE, Tyutyunnik PS, Khisamov AA (2014) Totally laparoscopic pancreatico-duodenectomy with tangential portal vein resection. Eur J Endosc Laparosc Surg 1(2):92–95 Khatkov IE, Izrailov RE, Tyutyunnik PS, Khisamov AA (2014) Totally laparoscopic pancreatico-duodenectomy with tangential portal vein resection. Eur J Endosc Laparosc Surg 1(2):92–95
15.
Zurück zum Zitat Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB (2010) Portal Vein Resection. Surg Clin N Am 90:309–322CrossRefPubMed Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB (2010) Portal Vein Resection. Surg Clin N Am 90:309–322CrossRefPubMed
16.
Zurück zum Zitat Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Buchler M, Charnley RM, Conlon K, Fernandez Cruz L, Dervenis C, Fingerhut A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR, International Study Group of Pancreatic Surgery (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988CrossRefPubMed Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Buchler M, Charnley RM, Conlon K, Fernandez Cruz L, Dervenis C, Fingerhut A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR, International Study Group of Pancreatic Surgery (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988CrossRefPubMed
17.
Zurück zum Zitat Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi VJ, Pisters PW (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1751–1756CrossRefPubMed Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi VJ, Pisters PW (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1751–1756CrossRefPubMed
18.
Zurück zum Zitat Callery MP, Chang KJ, Fishman EK, Talamonti MS, Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRefPubMed Callery MP, Chang KJ, Fishman EK, Talamonti MS, Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRefPubMed
19.
Zurück zum Zitat Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1736–1744CrossRefPubMed Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1736–1744CrossRefPubMed
20.
Zurück zum Zitat Buchs NC, Frossard JL, Rosset A, Chilcott M, Koutny-Fong P, Chassot G, Fasel JH, Poletti PA, Becker CD, Mentha G, Bühler L, Morel P (2007) Vascular invasion in pancreatic cancer: evaluation of endoscopic ultrasonography, computed tomography, ultrasonography, and angiography. Swiss Med Wkly 137(19–20):286–291PubMed Buchs NC, Frossard JL, Rosset A, Chilcott M, Koutny-Fong P, Chassot G, Fasel JH, Poletti PA, Becker CD, Mentha G, Bühler L, Morel P (2007) Vascular invasion in pancreatic cancer: evaluation of endoscopic ultrasonography, computed tomography, ultrasonography, and angiography. Swiss Med Wkly 137(19–20):286–291PubMed
21.
Zurück zum Zitat Hirono S, Yamaue H (2014) Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection. J Hepatobiliary Pancreat Sci. doi:10.1002/jhbp.184 Hirono S, Yamaue H (2014) Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection. J Hepatobiliary Pancreat Sci. doi:10.​1002/​jhbp.​184
22.
Zurück zum Zitat Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA (2012) “Artery-first” approaches to pancreatoduodenectomy. Br J Surg 99:1027–1035CrossRefPubMed Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA (2012) “Artery-first” approaches to pancreatoduodenectomy. Br J Surg 99:1027–1035CrossRefPubMed
24.
Zurück zum Zitat Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, Imrie CW, McKay CJ, Carter R (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251:1003–1010CrossRefPubMed Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, Imrie CW, McKay CJ, Carter R (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251:1003–1010CrossRefPubMed
25.
Zurück zum Zitat Boggi U, Amorese G, Vistoli F, Caniglia F, De Lio N, Perrone V, Barbarello L, Belluomini M, Signori S, Mosca F (2015) Laparoscopic pancreaticoduodenectomy: a systematic literature review. Surg Endosc 29(1):9–23CrossRefPubMed Boggi U, Amorese G, Vistoli F, Caniglia F, De Lio N, Perrone V, Barbarello L, Belluomini M, Signori S, Mosca F (2015) Laparoscopic pancreaticoduodenectomy: a systematic literature review. Surg Endosc 29(1):9–23CrossRefPubMed
26.
Zurück zum Zitat Pessaux P, Varma D, Arnaud J (2006) Pancreatoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg. 10:607–611CrossRefPubMed Pessaux P, Varma D, Arnaud J (2006) Pancreatoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg. 10:607–611CrossRefPubMed
27.
Zurück zum Zitat Ohigashi H, Ishikawa O, Eguchi H, Yamada T, Sasaki Y, Noura S et al (2004) Early ligation of the inferior pancreaticoduodenal artery to reduce blood loss during pancreaticoduodenectomy. Hepatogastroenterology 51:4–5PubMed Ohigashi H, Ishikawa O, Eguchi H, Yamada T, Sasaki Y, Noura S et al (2004) Early ligation of the inferior pancreaticoduodenal artery to reduce blood loss during pancreaticoduodenectomy. Hepatogastroenterology 51:4–5PubMed
28.
Zurück zum Zitat Kurosaki I, Minagawa M, Takano K, Takizawa K, Hatakeyama K (2011) Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head. JOP 12:220–229PubMed Kurosaki I, Minagawa M, Takano K, Takizawa K, Hatakeyama K (2011) Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head. JOP 12:220–229PubMed
29.
Zurück zum Zitat Nakao A, Takagi H (1993) Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 40:426–429PubMed Nakao A, Takagi H (1993) Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 40:426–429PubMed
30.
Zurück zum Zitat Zhang J, Qian HG, Leng JH et al (2009) Long mesentericoportal vein resection and end-to-end anastomosis without graft in pancreaticoduodenectomy. J Gastrointest Surg 13:1524–1528CrossRefPubMed Zhang J, Qian HG, Leng JH et al (2009) Long mesentericoportal vein resection and end-to-end anastomosis without graft in pancreaticoduodenectomy. J Gastrointest Surg 13:1524–1528CrossRefPubMed
31.
Zurück zum Zitat Lai EC (2012) Vascular resection and reconstruction at pancreatico-duodenectomy: technical issues. Hepatobiliary Pancreat Dis Int 11(3):234–242CrossRefPubMed Lai EC (2012) Vascular resection and reconstruction at pancreatico-duodenectomy: technical issues. Hepatobiliary Pancreat Dis Int 11(3):234–242CrossRefPubMed
32.
Zurück zum Zitat Khatkov I, Fingerhut A (2016) Pushing the limits of laparoscopic surgery: “how high is the sky?” or “when conversion is NOT needed”. Surg Innov 23(1):5–6CrossRefPubMed Khatkov I, Fingerhut A (2016) Pushing the limits of laparoscopic surgery: “how high is the sky?” or “when conversion is NOT needed”. Surg Innov 23(1):5–6CrossRefPubMed
33.
Zurück zum Zitat Katz MH, Ahmad S, Nelson H (2013) Borderline resectable pancreatic cancer: pushing the technical limits of surgery. Bull Am Coll Surg 98(1):61–63PubMed Katz MH, Ahmad S, Nelson H (2013) Borderline resectable pancreatic cancer: pushing the technical limits of surgery. Bull Am Coll Surg 98(1):61–63PubMed
34.
Zurück zum Zitat Fuks D, Cauchy F, Fteriche S, Nomi T, Schwarz L, Dokmak S, Scatton O, Fusco G, Belghiti J, Gayet B, Soubrane O (2016) Laparoscopy decreases pulmonary complications in patients undergoing major liver resection a propensity score analysis. Ann Surg 263:353–361CrossRefPubMed Fuks D, Cauchy F, Fteriche S, Nomi T, Schwarz L, Dokmak S, Scatton O, Fusco G, Belghiti J, Gayet B, Soubrane O (2016) Laparoscopy decreases pulmonary complications in patients undergoing major liver resection a propensity score analysis. Ann Surg 263:353–361CrossRefPubMed
Metadaten
Titel
Superior mesenteric–portal vein resection during laparoscopic pancreatoduodenectomy
verfasst von
Igor E. Khatkov
Roman E. Izrailov
Arthur A. Khisamov
Pavel S. Tyutyunnik
Abraham Fingerhut
Publikationsdatum
21.07.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 3/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5115-3

Weitere Artikel der Ausgabe 3/2017

Surgical Endoscopy 3/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.